Reaction profile

The FDA adverse-event record for pawing

354 FDA reports name pawing, a high-volume reaction in the CVM extract (VeDDRA 2592). Plate stamps and neighbourhood peers follow.

#805 of 2,481
by report volume (all reactions)
354
reports citing this reaction
5.4%
death-coded share
Dog
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Pawing has 354 reports now versus 335 in that prior snapshot: 19 more (5.7%).

Report change
+19
Death-coded reports
+2
Death-coded share
+0.3 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Pawing changes

FDA AER · VeDDRA plate

Code 2592 VOL-LOW

VOL-LOW · DEATH-PAR · MID-PACK · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-LOW 354 reports
  • DEATH-PAR 5.4%
  • MID-PACK #805/2481
  • PHOTO-FINISH Increased weight
  • SPECIES-DOG Dog · 196
  • DRUG-LEAD Moxidectin · 31
  • DESK-WIDE 20 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Increased weight (±1 reports)

Upper-third report volume drives the scale stamps on this plate; death-coded share and co-report peers follow. Not a clinical diagnosis.

High-volume neighbourhood around Pawing

Upper-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Skin tumour NOS · near355Pawing · this reaction354Increased weight · near353Nasal congestion · near353Purulent lesion(s) · near353Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Pawing

Pawing: low death-coded share in the FDA AER plate

Signature read: Pawing's 5.4% death-coded share is among the lowest in the openFDA reaction corpus. Report volume is upper-third scale: 354 named reports in the openFDA extract. Death-coded share is lower-third: 19 of 354 reports (5.4% of named reports). Nearest volume peer: Increased weight (±1 reports). Lead species Dog (196). Lead co-reported drug Moxidectin (31).

Read these counts as reporting volume, not risk: per our methodology, Lead co-reported drug Moxidectin appears in filings alongside this reaction; that is association, not causation. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 196
Horse 90
Cat 66
Cattle 2

Breeds Most Affected

Domestic Shorthair 40
Quarter Horse 24
Chihuahua 13
Retriever - Golden 12
Retriever - Labrador 11
Thoroughbred 10
Horse (unknown) 10
Crossbred Canine/dog 9
Dachshund (unspecified) 9
Terrier - Yorkshire 8

Associated Drugs

Moxidectin 31
Florfenicol + Mometasone Furoate + Terbinafine Hydrochloride 30
Clodronate Disodium 28
Afoxolaner 15
Ceftiofur Crystalline Free Acid 15
Buprenorphine 13
Maropitant Citrate 12
Fluralaner Spot-On Solution 11
Pyrantel Pamoate;Sarolaner 11
Carprofen 10
Firocoxib 9
Selamectin 9
Polysulfated Glycosaminoglycan 9
Fluralaner 13.64% 12-Week Chew 9
Bordetella Vaccine 8
Flunixin Meglumine Injectable 7
Sarolaner 7
Mirtazapine 7
Florfenicol, Terbinafine, Betamethasone Acetate 7
Phenylbutazone 6

Nationwide reactions with similar profiles

Two openFDA-derived peer sets for Pawing, both floored at ≥50 reports so the neighborhoods stay in the advertised mass (the volume chart above is the unfloored photo-finish strip).

Similar report volume

Nearest other reactions by FDA report count (354 here).

Similar death-coded share

Nearest other reactions by death-coded share (5.4% here), distinct from the volume row.

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Pawing (#805 of 2,481 by report volume); death-coded 5.4%. PlainBreed reaction plate · death-coded share stamp 5.4% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →